333 related articles for article (PubMed ID: 28940814)
1. Preanalytical blood sample workup for cell-free DNA analysis using Droplet Digital PCR for future molecular cancer diagnostics.
van Ginkel JH; van den Broek DA; van Kuik J; Linders D; de Weger R; Willems SM; Huibers MMH
Cancer Med; 2017 Oct; 6(10):2297-2307. PubMed ID: 28940814
[TBL] [Abstract][Full Text] [Related]
2. Optimized (Pre) Analytical Conditions and Workflow for Droplet Digital PCR Analysis of Cell-Free DNA from Patients with Suspected Lung Carcinoma.
de Kock R; Deiman B; Kraaijvanger R; Scharnhorst V
J Mol Diagn; 2019 Sep; 21(5):895-902. PubMed ID: 31229652
[TBL] [Abstract][Full Text] [Related]
3. An improved digital polymerase chain reaction protocol to capture low-copy KRAS mutations in plasma cell-free DNA by resolving 'subsampling' issues.
Ono Y; Sugitani A; Karasaki H; Ogata M; Nozaki R; Sasajima J; Yokochi T; Asahara S; Koizumi K; Ando K; Hironaka K; Daito T; Mizukami Y
Mol Oncol; 2017 Oct; 11(10):1448-1458. PubMed ID: 28691390
[TBL] [Abstract][Full Text] [Related]
4. Denaturation-Enhanced Droplet Digital PCR for Liquid Biopsies.
Fitarelli-Kiehl M; Yu F; Ashtaputre R; Leong KW; Ladas I; Supplee J; Paweletz C; Mitra D; Schoenfeld JD; Parangi S; Makrigiorgos GM
Clin Chem; 2018 Dec; 64(12):1762-1771. PubMed ID: 30274976
[TBL] [Abstract][Full Text] [Related]
5. A Study of Pre-Analytical Variables and Optimization of Extraction Method for Circulating Tumor DNA Measurements by Digital Droplet PCR.
Cavallone L; Aldamry M; Lafleur J; Lan C; Gonzalez Ginestet P; Alirezaie N; Ferrario C; Aguilar-Mahecha A; Basik M
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):909-916. PubMed ID: 30824523
[TBL] [Abstract][Full Text] [Related]
6. A Comparison of Cell-Free DNA Isolation Kits: Isolation and Quantification of Cell-Free DNA in Plasma.
Sorber L; Zwaenepoel K; Deschoolmeester V; Roeyen G; Lardon F; Rolfo C; Pauwels P
J Mol Diagn; 2017 Jan; 19(1):162-168. PubMed ID: 27865784
[TBL] [Abstract][Full Text] [Related]
7. Digital PCR-Based Detection of EGFR Mutations in Paired Plasma and CSF Samples of Lung Adenocarcinoma Patients with Central Nervous System Metastases.
Huang R; Xu X; Li D; Chen K; Zhan Q; Ge M; Zhou X; Liang X; Guan M
Target Oncol; 2019 Jun; 14(3):343-350. PubMed ID: 31161597
[TBL] [Abstract][Full Text] [Related]
8. Multiplex KRASG12/G13 mutation testing of unamplified cell-free DNA from the plasma of patients with advanced cancers using droplet digital polymerase chain reaction.
Janku F; Huang HJ; Fujii T; Shelton DN; Madwani K; Fu S; Tsimberidou AM; Piha-Paul SA; Wheler JJ; Zinner RG; Naing A; Hong DS; Karp DD; Cabrilo G; Kopetz ES; Subbiah V; Luthra R; Kee BK; Eng C; Morris VK; Karlin-Neumann GA; Meric-Bernstam F
Ann Oncol; 2017 Mar; 28(3):642-650. PubMed ID: 27993791
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor DNA tracking through driver mutations as a liquid biopsy-based biomarker for uveal melanoma.
Bustamante P; Tsering T; Coblentz J; Mastromonaco C; Abdouh M; Fonseca C; Proença RP; Blanchard N; Dugé CL; Andujar RAS; Youhnovska E; Burnier MN; Callejo SA; Burnier JV
J Exp Clin Cancer Res; 2021 Jun; 40(1):196. PubMed ID: 34134723
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood.
Kresse SH; Brandt-Winge S; Pharo H; Flatin BTB; Jeanmougin M; Vedeld HM; Lind GE
Clin Epigenetics; 2023 Sep; 15(1):151. PubMed ID: 37710283
[TBL] [Abstract][Full Text] [Related]
11. Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors.
Seki Y; Fujiwara Y; Kohno T; Takai E; Sunami K; Goto Y; Horinouchi H; Kanda S; Nokihara H; Watanabe S; Ichikawa H; Yamamoto N; Kuwano K; Ohe Y
Oncologist; 2016 Feb; 21(2):156-64. PubMed ID: 26768482
[TBL] [Abstract][Full Text] [Related]
12. Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.
van Ginkel JH; Huibers MMH; van Es RJJ; de Bree R; Willems SM
BMC Cancer; 2017 Jun; 17(1):428. PubMed ID: 28629339
[TBL] [Abstract][Full Text] [Related]
13. Blood Collection and Cell-Free DNA Isolation Methods Influence the Sensitivity of Liquid Biopsy Analysis for Colorectal Cancer Detection.
Barták BK; Kalmár A; Galamb O; Wichmann B; Nagy ZB; Tulassay Z; Dank M; Igaz P; Molnár B
Pathol Oncol Res; 2019 Jul; 25(3):915-923. PubMed ID: 29374860
[TBL] [Abstract][Full Text] [Related]
14. Application of circulating tumor DNA in prospective clinical oncology trials - standardization of preanalytical conditions.
van Dessel LF; Beije N; Helmijr JC; Vitale SR; Kraan J; Look MP; de Wit R; Sleijfer S; Jansen MP; Martens JW; Lolkema MP
Mol Oncol; 2017 Mar; 11(3):295-304. PubMed ID: 28164427
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of Response and Resistance in Plasma of EGFR-Mutant Lung Cancer Using Droplet Digital PCR.
Kuang Y; O'Connell A; Sacher AG; Feeney N; Alden RS; Oxnard GR; Paweletz CP
Methods Mol Biol; 2018; 1768():193-207. PubMed ID: 29717445
[TBL] [Abstract][Full Text] [Related]
16. Molecular Analysis of Circulating Cell-Free DNA from Lung Cancer Patients in Routine Laboratory Practice: A Cross-Platform Comparison of Three Different Molecular Methods for Mutation Detection.
Bartels S; Persing S; Hasemeier B; Schipper E; Kreipe H; Lehmann U
J Mol Diagn; 2017 Sep; 19(5):722-732. PubMed ID: 28723342
[TBL] [Abstract][Full Text] [Related]
17. Impact of Preanalytical and Analytical Methods on Cell-Free DNA Diagnostics.
Krasic J; Abramovic I; Vrtaric A; Nikolac Gabaj N; Kralik-Oguic S; Katusic Bojanac A; Jezek D; Sincic N
Front Cell Dev Biol; 2021; 9():686149. PubMed ID: 34552921
[TBL] [Abstract][Full Text] [Related]
18. Total DNA input is a crucial determinant of the sensitivity of plasma cell-free DNA EGFR mutation detection using droplet digital PCR.
Zhang Y; Xu Y; Zhong W; Zhao J; Chen M; Zhang L; Li L; Wang M
Oncotarget; 2017 Jan; 8(4):5861-5873. PubMed ID: 28052016
[TBL] [Abstract][Full Text] [Related]
19. Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology.
Ponti G; Manfredini M; Tomasi A
Crit Rev Oncol Hematol; 2019 Sep; 141():36-42. PubMed ID: 31212145
[TBL] [Abstract][Full Text] [Related]
20. Circulating Cell-Free DNA and RNA Analysis as Liquid Biopsy: Optimal Centrifugation Protocol.
Sorber L; Zwaenepoel K; Jacobs J; De Winne K; Goethals S; Reclusa P; Van Casteren K; Augustus E; Lardon F; Roeyen G; Peeters M; Van Meerbeeck J; Rolfo C; Pauwels P
Cancers (Basel); 2019 Mar; 11(4):. PubMed ID: 30935089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]